Get the Stockscreener App
121.41
1.82%
2.17
Overview
News
Price History
Option Chain
Financials
Discussions
Forecast
Stock Split
Dividend History
Merck Co Inc stock is traded at $121.41, with a volume of 10.10M.
It is up +1.82% in the last 24 hours and up +12.15% over the past month.
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform, led by Keytruda, is a major contributor to overall sales. The company also has a substantial vaccine business aimed at preventing pediatric diseases, as well as Gardasil for human papillomavirus. Additionally, Merck sells animal health-related drugs. From a geographical perspective, 47% of the company's sales are generated from US human health (pharmaceuticals and vaccines).
See More
Previous Close:
$119.24
Open:
$121.5
24h Volume:
10.10M
Relative Volume:
0.70
Market Cap:
$301.34B
Revenue:
$65.00B
Net Income/Loss:
$18.26B
P/E Ratio:
16.69
EPS:
7.2751
Net Cash Flow:
$13.05B
1W Performance:
-0.43%
1M Performance:
+12.15%
6M Performance:
+46.79%
1Y Performance:
+43.82%
1-Day Range:
$121.03
$123.33
1-Week Range:
$116.10
$123.33
52-Week Range:
$73.31
$123.33
Merck Co Inc Stock (MRK) Company Profile
Name
Merck Co Inc
Sector
Industry
Phone
908-740-4000
Address
126 EAST LINCOLN AVENUE, RAHWAY, NJ
Compare MRK vs LLY, JNJ, ABBV, AZN, NVS
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
MRK
Merck Co Inc
|
121.41 | 295.96B | 65.00B | 18.26B | 13.05B | 7.2751 |
|
LLY
Lilly Eli Co
|
1,040.00 | 929.27B | 65.18B | 20.64B | 5.96B | 22.59 |
|
JNJ
Johnson Johnson
|
243.45 | 589.19B | 94.19B | 26.80B | 19.70B | 11.05 |
|
ABBV
Abbvie Inc
|
231.50 | 402.08B | 61.16B | 4.20B | 19.68B | 2.3671 |
|
AZN
Astrazeneca Plc
|
205.55 | 317.06B | 58.80B | 10.24B | 8.98B | 3.2788 |
|
NVS
Novartis Ag Adr
|
163.10 | 307.56B | 54.72B | 14.02B | 15.32B | 7.1855 |
Merck Co Inc Stock (MRK) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-08-26 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Dec-18-25 | Upgrade | BMO Capital Markets | Market Perform → Outperform |
| Nov-24-25 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Nov-13-25 | Initiated | Scotiabank | Sector Outperform |
| Oct-13-25 | Resumed | Citigroup | Neutral |
| Sep-17-25 | Downgrade | Berenberg | Buy → Hold |
| May-14-25 | Downgrade | Citigroup | Buy → Neutral |
| Apr-22-25 | Initiated | Cantor Fitzgerald | Neutral |
| Feb-18-25 | Downgrade | Deutsche Bank | Buy → Hold |
| Feb-10-25 | Downgrade | TD Cowen | Buy → Hold |
| Jan-08-25 | Downgrade | Truist | Buy → Hold |
| Dec-20-24 | Downgrade | BMO Capital Markets | Outperform → Market Perform |
| Dec-10-24 | Resumed | BofA Securities | Buy |
| Dec-04-24 | Upgrade | HSBC Securities | Hold → Buy |
| Nov-15-24 | Initiated | Wolfe Research | Peer Perform |
| Nov-11-24 | Downgrade | Daiwa Securities | Buy → Neutral |
| Oct-17-24 | Initiated | Bernstein | Mkt Perform |
| Mar-11-24 | Downgrade | Societe Generale | Hold → Sell |
| Jan-04-24 | Upgrade | TD Cowen | Market Perform → Outperform |
| Nov-09-23 | Initiated | Deutsche Bank | Buy |
| Oct-27-23 | Upgrade | BMO Capital Markets | Market Perform → Outperform |
| Oct-20-23 | Upgrade | UBS | Neutral → Buy |
| Jul-14-23 | Initiated | HSBC Securities | Hold |
| Apr-13-23 | Upgrade | Citigroup | Neutral → Buy |
| Mar-28-23 | Downgrade | Societe Generale | Buy → Hold |
| Mar-13-23 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Mar-06-23 | Initiated | Jefferies | Buy |
| Feb-22-23 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Jan-04-23 | Upgrade | BofA Securities | Neutral → Buy |
| Nov-18-22 | Initiated | Credit Suisse | Outperform |
| Oct-10-22 | Upgrade | Guggenheim | Neutral → Buy |
| Sep-14-22 | Upgrade | Berenberg | Hold → Buy |
| Jul-06-22 | Upgrade | Daiwa Securities | Neutral → Buy |
| Jun-06-22 | Resumed | SVB Leerink | Outperform |
| Apr-06-22 | Resumed | Morgan Stanley | Equal-Weight |
| Dec-17-21 | Initiated | Goldman | Buy |
| Dec-16-21 | Initiated | Daiwa Securities | Neutral |
| Dec-13-21 | Downgrade | UBS | Buy → Neutral |
| Dec-09-21 | Initiated | Wells Fargo | Overweight |
| Dec-07-21 | Downgrade | Guggenheim | Buy → Neutral |
| Nov-29-21 | Downgrade | Citigroup | Buy → Neutral |
| Nov-19-21 | Initiated | BMO Capital Markets | Market Perform |
| Nov-01-21 | Upgrade | Argus | Hold → Buy |
| Sep-07-21 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jul-27-21 | Resumed | Truist | Buy |
| May-20-21 | Downgrade | Argus | Buy → Hold |
| Apr-07-21 | Resumed | RBC Capital Mkts | Sector Perform |
| Nov-10-20 | Resumed | Bernstein | Outperform |
| Sep-29-20 | Initiated | Berenberg | Hold |
| Aug-03-20 | Upgrade | Goldman | Neutral → Buy |
| Jun-12-20 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| Feb-27-20 | Initiated | Barclays | Overweight |
| Jan-07-20 | Initiated | RBC Capital Mkts | Sector Perform |
| Oct-17-19 | Resumed | BofA/Merrill | Neutral |
| Aug-16-19 | Initiated | SVB Leerink | Outperform |
| Jul-03-19 | Initiated | Mizuho | Buy |
| May-28-19 | Initiated | Goldman | Neutral |
| May-13-19 | Upgrade | Atlantic Equities | Neutral → Overweight |
| Oct-16-18 | Reiterated | Citigroup | Buy |
| Oct-09-18 | Resumed | Guggenheim | Buy |
| Apr-23-18 | Upgrade | Goldman | Neutral → Buy |
| Apr-17-18 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Apr-05-18 | Upgrade | Barclays | Equal Weight → Overweight |
| Mar-12-18 | Upgrade | Leerink Partners | Mkt Perform → Outperform |
| Feb-14-18 | Reiterated | Leerink Partners | Mkt Perform |
| Feb-07-18 | Reiterated | Morgan Stanley | Equal-Weight |
| Jan-16-18 | Upgrade | SunTrust | Hold → Buy |
View All
Merck Co Inc Stock (MRK) Latest News
Merck & Co., Inc. $MRK Shares Sold by Shell Asset Management Co. - MarketBeat
State of New Jersey Common Pension Fund D Has $73.74 Million Stock Holdings in Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. $MRK Shares Acquired by Calton & Associates Inc. - MarketBeat
Hardy Reed LLC Sells 8,831 Shares of Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. $MRK Shares Bought by HighTower Advisors LLC - MarketBeat
Aberdeen Group plc Sells 46,708 Shares of Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. $MRK Shares Sold by ABN Amro Investment Solutions - MarketBeat
Merck stock price hits a 52-week high on Deutsche Bank upgrade as MRK heads into holiday week - TechStock²
2 Unstoppable Dividend Stocks to Buy If There's a Stock Market Sell-Off - The Motley Fool
Merck & Co., Inc. $MRK Shares Sold by Public Sector Pension Investment Board - MarketBeat
Ameritas Advisory Services LLC Has $1.16 Million Holdings in Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. (NYSE:MRK) Hits New 1-Year High Following Analyst Upgrade - MarketBeat
Merck & Co Inc (MRK) Stock Price, Trades & News - GuruFocus
Merck & Co. (MRK) Announces FDA Approval of KEYTRUDA and KEYTRUDA QLEX Plus Paclitaxel, With or Without Bevacizumab, to Treat Adults With PD-L1+ - Finviz
Merck & Co., Inc. (MRK) is Attracting Investor Attention: Here is What You Should Know - Yahoo Finance
Merck & Co., Inc. (NYSE:MRK) Upgraded to Buy at Deutsche Bank Aktiengesellschaft - MarketBeat
Merck & Co., Inc. $MRK Shares Sold by Metis Global Partners LLC - MarketBeat
Mraz Amerine & Associates Inc. Grows Stock Position in Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. $MRK Shares Purchased by Savvy Advisors Inc. - MarketBeat
Insider Sell Alert: Chirfi Guindo Sells 10,000 Shares of Merck & Co Inc (MRK) - GuruFocus
Merck & Co., Inc. $MRK Shares Acquired by Varma Mutual Pension Insurance Co - MarketBeat
LSV Asset Management Has $444.77 Million Stock Position in Merck & Co., Inc. $MRK - MarketBeat
Krilogy Financial LLC Buys 21,122 Shares of Merck & Co., Inc. $MRK - MarketBeat
Caprock Group LLC Invests $5.33 Million in Merck & Co., Inc. $MRK - MarketBeat
Atria Investments Inc Has $15.08 Million Stock Position in Merck & Co., Inc. $MRK - MarketBeat
ABC Arbitrage SA Buys Shares of 11,779 Merck & Co., Inc. $MRK - MarketBeat
Merck's Keytruda Gets New FDA Approval For Expanded Use In Pretreated Ovarian Cancer Patients - Benzinga
Rhumbline Advisers Sells 8,850 Shares of Merck & Co., Inc. $MRK - MarketBeat
Stratos Wealth Partners LTD. Acquires 26,639 Shares of Merck & Co., Inc. $MRK - MarketBeat
Wealthfront Advisers LLC Raises Stock Holdings in Merck & Co., Inc. $MRK - MarketBeat
ING Groep NV Raises Stock Holdings in Merck & Co., Inc. $MRK - MarketBeat
Edgemoor Investment Advisors Inc. Cuts Stake in Merck & Co., Inc. $MRK - MarketBeat
Advisors Asset Management Inc. Grows Holdings in Merck & Co., Inc. $MRK - MarketBeat
Insider Sell Alert: Dean Li Sells Shares of Merck & Co Inc (MRK) - GuruFocus
Merck & Co., Inc. $MRK Shares Sold by Wesbanco Bank Inc. - MarketBeat
Merck & Co., Inc. $MRK Shares Sold by Applied Finance Capital Management LLC - MarketBeat
Merck & Co., Inc. $MRK Shares Sold by ProShare Advisors LLC - MarketBeat
Rockland Trust Co. Boosts Stock Holdings in Merck & Co., Inc. $MRK - MarketBeat
Midwest Trust Co Purchases 24,910 Shares of Merck & Co., Inc. $MRK - MarketBeat
Rothschild & Co Redburn Adjusts Price Target on Merck & Co. to $140 From $135, Maintains Buy Rating - marketscreener.com
Merck & Co., Inc. $MRK Position Increased by Providence Capital Advisors LLC - MarketBeat
Costello Asset Management INC Decreases Stake in Merck & Co., Inc. $MRK - MarketBeat
MRK Stock Price, Forecast & Analysis | MERCK & CO. INC. (NYSE:MRK) - ChartMill
Insider Sell: Chirfi Guindo Sells 10,000 Shares of Merck & Co In - GuruFocus
Merck & Co., Inc. (NYSE:MRK) EVP Sells $14,485,422.95 in Stock - MarketBeat
Chirfi Guindo Sells 10,000 Shares of Merck & Co., Inc. (NYSE:MRK) Stock - MarketBeat
Merck: The Spike Doesn't Make It Overvalued (NYSE:MRK) - Seeking Alpha
Merck Stock Surged 40% Last Year. Is it Still a Buy in 2026? - TIKR.com
Merck: A Buy For 2026, But The Clock Is Still Ticking (NYSE:MRK) - Seeking Alpha
OPTIMAS CAPITAL Ltd Makes New Investment in Merck & Co., Inc. $MRK - MarketBeat
Oppenheimer Asset Management Inc. Has $46.50 Million Holdings in Merck & Co., Inc. $MRK - MarketBeat
Merck Co Inc Stock (MRK) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.19%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):